Harbour Capital Advisors, LLC Gilead Sciences, Inc. Transaction History

Harbour Capital Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $437,054 - $498,003	-7,715 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$62.1 - $78.08 $252,126 - $317,004	-4,060 Reduced 34.48%	7,715 $488,000
Q2 2020 Jul 21, 2020	SELL	$72.34 - $84.0 $16,348 - $18,984	-226 Reduced 1.88%	11,775 $906,000
Q1 2020 Apr 08, 2020	SELL	$62.63 - $80.22 $174,862 - $223,974	-2,792 Reduced 18.87%	12,001 $897,000
Q4 2019 Jan 22, 2020	SELL	$61.62 - $67.78 $545,398 - $599,920	-8,851 Reduced 37.43%	14,793 $961,000
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $191,718 - $211,623	3,067 Added 14.9%	23,644 $1.5 Million
Q2 2019 Jul 10, 2019	BUY	$61.87 - $69.38 $75,172 - $84,296	1,215 Added 6.28%	20,577 $1.39 Million
Q1 2019 Apr 24, 2019	BUY	$62.53 - $70.05 $161,327 - $180,729	2,580 Added 15.37%	19,362 $1.26 Million
Q4 2018 Jan 23, 2019	BUY	$60.54 - $79.0 $87,480 - $114,155	1,445 Added 9.42%	16,782 $1.05 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $173,923 - $192,564	-2,440 Reduced 13.73%	15,337 $1.18 Million
Q2 2018 Jul 11, 2018	SELL	$64.88 - $75.68 $19,464 - $22,704	-300 Reduced 1.66%	17,777 $1.27 Million
Q1 2018 Apr 18, 2018	SELL	$72.84 - $88.8 $24,037 - $29,304	-330 Reduced 1.79%	18,077 $1.36 Million
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $59,766 - $70,156	840 Added 4.78%	18,407 $1.32 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $1.27 Million - $1.5 Million	17,567	17,567 $1.42 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbour Capital Advisors, LLC with notifications on news.